Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7318 p412
25 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Medication review training programme to be launched in Scotland

A medication review training programme for community pharmacists in Scotland is to be launched this autumn.

The programme is part of a national clinical skills training programme which is being developed by NHS Education for Scotland (NES). It is hoped that the programme will help community pharmacists to prepare for the new contract.

The programme is to be based on the work of the pharmaceutical care model scheme for the frail elderly. Some NHS boards have already used this model scheme to help pharmacists to develop the generic skills to undertake medication reviews. Now the new programme will allow community pharmacists in other NHS board areas to develop medication review skills. The programme will be piloted in the autumn and will then be rolled out in January 2005.

Annamarie McGregor, director of the pharmaceutical care model schemes, commented: “As we head towards the new contract, we — the Scottish Pharmaceutical General Council, the Scottish Executive Health Department, the pharmaceutical care model schemes, NES and chief pharmacists — are all working together to support community pharmacists. This initiative is based on great groundwork in NHS boards throughout Scotland and I would encourage people to get involved locally.”

The next component of the national clinical skills training programme will be based on the work of two more pharmaceutical care model schemes — for epilepsy and asthma. NES has developed training from this work that will be delivered in all NHS Board areas by March 2005.

To support the national clinical skills training programme, NES has designed an accredited “training for trainers” course to enable trainers to deliver standardised training throughout Scotland. One course was run last month and this will be extended later this year. Peer review and mentoring models are also being explored to support the programme.

Back to Top


©The Pharmaceutical Journal